Gene Network Analysis for Osteoporosis, Sarcopenia, Diabetes, and Obesity in Human Mesenchymal Stromal Cells
- PMID: 35328013
- PMCID: PMC8953569
- DOI: 10.3390/genes13030459
Gene Network Analysis for Osteoporosis, Sarcopenia, Diabetes, and Obesity in Human Mesenchymal Stromal Cells
Abstract
The systemic gene interactions that occur during osteoporosis and their underlying mechanisms remain to be determined. To this end, mesenchymal stromal cells (MSCs) were analyzed from bone marrow samples collected from healthy individuals (n = 5) and patients with osteoporosis (n = 5). A total of 120 osteoporosis-related genes were identified using RNA-sequencing (RNA-seq) and Ingenuity Pathway Analysis (IPA) software. In order to analyze these genes, we constructed a heatmap of one-way hierarchical clustering and grouped the gene expression patterns of the samples. The MSCs from one control participant showed a similar expression pattern to that observed in the MSCs of three patients with osteoporosis, suggesting that the differentiating genes might be important genetic determinants of osteoporosis. Then, we selected the top 38 genes based on fold change and expression, excluding osteoporosis-related genes from the control participant. We identified a network among the top 38 genes related to osteoblast and osteoclast differentiation, bone remodeling, osteoporosis, and sarcopenia using the Molecule Activity Predictor program. Among them, 25 genes were essential systemic genes involved in osteoporosis. Furthermore, we identified 24 genes also associated with diabetes and obesity, among which 10 genes were involved in a network related to bone and energy metabolism. The study findings may have implications for the treatment and prevention of osteoporosis.
Keywords: gene network analysis; mesenchymal stromal cells; osteoporosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Validation of Osteogenic Properties of Cytochalasin D by High-Resolution RNA-Sequencing in Mesenchymal Stem Cells Derived from Bone Marrow and Adipose Tissues.Stem Cells Dev. 2018 Aug 15;27(16):1136-1145. doi: 10.1089/scd.2018.0037. Epub 2018 Jul 23. Stem Cells Dev. 2018. PMID: 29882479 Free PMC article.
-
Transcriptional profiling of human femoral mesenchymal stem cells in osteoporosis and its association with adipogenesis.Gene. 2017 Oct 20;632:7-15. doi: 10.1016/j.gene.2017.08.015. Epub 2017 Aug 24. Gene. 2017. PMID: 28844671
-
Gene expression changes in human mesenchymal stem cells from patients with osteoporosis.Mol Med Rep. 2015 Jul;12(1):981-7. doi: 10.3892/mmr.2015.3514. Epub 2015 Mar 19. Mol Med Rep. 2015. PMID: 25815782 Free PMC article.
-
Recent genetic discoveries in osteoporosis, sarcopenia and obesity.Endocr J. 2015;62(6):475-84. doi: 10.1507/endocrj.EJ15-0154. Epub 2015 Apr 11. Endocr J. 2015. PMID: 25866211 Review.
-
Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis.Curr Stem Cell Res Ther. 2008 Sep;3(3):208-18. doi: 10.2174/157488808785740325. Curr Stem Cell Res Ther. 2008. PMID: 18782003 Review.
References
-
- Obesity and Overweight: Factsheet. [(accessed on 22 November 2018)]. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical